Randomised controlled trial of simvastatin treatment for autism in young children with neurofibromatosis type 1 (SANTA)

BACKGROUND: Neurofibromatosis 1 (NF1) is a monogenic model for syndromic autism. Statins rescue the social and cognitive phenotype in animal knockout models, but translational trials with subjects > 8 years using cognition/behaviour outcomes have shown mixed results. This trial breaks new ground...

Descripción completa

Detalles Bibliográficos
Autores principales: Stivaros, Stavros, Garg, Shruti, Tziraki, Maria, Cai, Ying, Thomas, Owen, Mellor, Joseph, Morris, Andrew A., Jim, Carly, Szumanska-Ryt, Karolina, Parkes, Laura M, Haroon, Hamied A., Montaldi, Daniela, Webb, Nicholas, Keane, John, Castellanos, Francisco X., Silva, Alcino J., Huson, Sue, Williams, Stephen, Gareth Evans, D., Emsley, Richard, Green, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824534/
https://www.ncbi.nlm.nih.gov/pubmed/29484149
http://dx.doi.org/10.1186/s13229-018-0190-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824534/
https://www.ncbi.nlm.nih.gov/pubmed/29484149
http://dx.doi.org/10.1186/s13229-018-0190-z

Ejemplares similares